Open access
Jul 2026
Humanized B-hIL4/hIL4RA/hTSLP/hTSLPR plus mice Model for Efficacy and Toxicity Evaluation 2302190
The humanized B-hIL4/hIL4RA/hTSLP/hTSLP/hTSLPR plus mice model serves as an excellent platform for assessing the efficacy and safety of human IL-4RA and TSLP-related antibodies and the combination of anti-IL4RA and anti-TSLP antibody therapies demonstrated enhanced therapeutic efficacy.
Yuan Tian, Biying Hong, Liya Yang et al.
· Journal of Immunology · 0 citations